Eye News and Research

Latest Eye News and Research

AAO to recognize UH optometry dean with Charles F. Prentice Medal Award

Earl L. Smith III, O.D., dean of the College of Optometry and Greeman-Petty Professor at the University of Houston, is the 2010 recipient of the Charles F. Prentice Medal Award from the American Academy of Optometry.

19 Nov 2010

Multinational team identifies novel retinal disease gene

A multinational team effort of Regensburg's Institute of Human Genetics, Washington University in St. Louis, other partners and Genomatix elucidated a transcriptional network in photoreceptors and thereby identified a novel retinal disease gene

19 Nov 2010

OXiGENE updates data on FALCON trial for non-small cell lung cancer

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).

19 Nov 2010

Call for more transparency and improvements to drug safety in Canada

A commissioned discussion paper released today by the Health Council of Canada, Keeping an Eye on Prescription Drugs, Keeping Canadians Safe, underscores the many limitations to how drug safety and effectiveness is monitored and reported in Canada. The report provides clear recommendations for changes to the current system to ensure Canadians are safe from undue pharmaceutical harm.

18 Nov 2010

OptiMedica's Catalys Precision Laser System improves precision in cataract surgery

Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine.

18 Nov 2010

Researchers unveil novel oncogene associated with uveal melanoma

An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer.

18 Nov 2010

States consider options for funding Medicaid

The Billings Gazette: Montana lawmakers questioned the state's top health official "about plans to hire a private company to manage part of Medicaid, asking why the administration hasn't had a more public discussion on the proposal." The Legislative Finance Committee also listened to "health care providers and former officials who experienced the state's 1995 foray into private management of Medicaid for the mentally ill — and how it became a disaster for its low-income patients and their providers."

18 Nov 2010

FDA grants three years of marketing exclusivity to ISTA's BROMDAY

ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act.

18 Nov 2010

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

The Krieger Eye Institute at Sinai Hospital opened a new center for the treatment of retinal diseases in November. The retina is the layer of tissue at the back of the eye that converts images to electrical impulses. These electrical signals are then perceived by the brain as sight.

18 Nov 2010

Asbestos problem in NSW needs government attention: Report

A report from the NSW Ombudsman says that the state government is failing to deal with the deadly issue of asbestos despite repeated warnings regarding “immense” amounts of the dangerous material still scattered across NSW.

17 Nov 2010

Popular Science names VisionCare's Implantable Miniature Telescope for AMD 'Best of What's New' 2010

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degeneration (AMD) is named "Best of What's New" 2010 by Popular Science magazine.

17 Nov 2010

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.

17 Nov 2010

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

Two experimental brain-machine technologies - deep brain stimulation coupled with physical therapy and a thought-controlled computer system-may offer new therapies for people with stroke and brain injuries, new human research shows. In addition, an animal study shows a new artificial retina may restore vision better than existing prosthetics. The findings were announced today at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

New findings suggest brain sensory regions overlap to help people interpret environment

New research indicates that the integration of senses and functions in the brain is common. About two percent of the population has a condition called synesthesia, in which two different sensations, like color and sound, are experienced at once.

17 Nov 2010

New AAC devices can help patients with neurological conditions to communicate

Though many people suffering from neurological conditions such as cerebral palsy and Lou Gehrig's disease have lost their ability to speak, they can communicate using augmentative and alternative communications (AAC) devices such as keyboards, head sticks, and other hands-free options.

17 Nov 2010

Avedro's KXL System for corneal cross-linking granted European CE Mark

Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.

17 Nov 2010

SMI launches high-speed remote eye tracker

Just in time for the SfN Neuroscience 2010 Conference in San Diego, USA, SMI launches the RED500. The RED500 is the world's first high-performance and high-speed remote eye tracker, with 500Hz sampling rate, binocular tracking and a large tracking range.

16 Nov 2010

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk Institute for Biological Studies. The study, published in the online edition of Human Molecular Genetics, sets the stage for further investigations into fisetin's neuroprotective properties in Huntington's and other neurodegenerative conditions.

16 Nov 2010

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology in Phoenix, Nov. 11-16. The underdiagnosis, undertreatment and self-treatment of eye allergies may seriously diminish quality of life, allergists say.

16 Nov 2010

RXi third quarter net loss increases to $4.1 million

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.

15 Nov 2010

Eye News and Research

Latest Eye News and Research

AAO to recognize UH optometry dean with Charles F. Prentice Medal Award

Multinational team identifies novel retinal disease gene

OXiGENE updates data on FALCON trial for non-small cell lung cancer

Call for more transparency and improvements to drug safety in Canada

OptiMedica's Catalys Precision Laser System improves precision in cataract surgery

Researchers unveil novel oncogene associated with uveal melanoma

States consider options for funding Medicaid

FDA grants three years of marketing exclusivity to ISTA's BROMDAY

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

Asbestos problem in NSW needs government attention: Report

Popular Science names VisionCare's Implantable Miniature Telescope for AMD 'Best of What's New' 2010

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

New findings suggest brain sensory regions overlap to help people interpret environment

New AAC devices can help patients with neurological conditions to communicate

Avedro's KXL System for corneal cross-linking granted European CE Mark

SMI launches high-speed remote eye tracker

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

RXi third quarter net loss increases to $4.1 million

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in